BACKGROUND: Cardiovascular disease mortality has declined and diabetes mortality has increased in high-income countries. We estimated the potential role of trends in population body mass index, systolic blood pressure, serum total cholesterol and smoking in cardiometabolic mortality decline in 26 industrialized countries. METHODS: Mortality data were from national vital statistics. Body mass index, systolic blood pressure and serum total cholesterol were from a systematic analysis of population-based data. We estimated the associations between change in cardiometabolic mortality and changes in risk factors, adjusted for change in per-capita gross domestic product. We calculated the potential contribution of risk factor trends to mortality decline. RESULTS: Between 1980 and 2009, age-standardized cardiometabolic mortality declined in all 26 countries, with the annual decline between <1% in Mexico to ≈ 5% in Australia. Across the 26 countries together, risk factor trends may have accounted for ≈ 48% (men) and ≈ 40% (women) of cardiometabolic mortality decline. Risk factor trends may have accounted for >60% of decline among men and women in Finland and Switzerland, men in New Zealand and France, and women in Italy; their benefits were smallest in Mexican, Portuguese, and Japanese men and Mexican women. Risk factor trends may have slowed down mortality decline in Chilean men and women and had virtually no effect in Argentinean women. The contributions of risk factors to mortality decline seemed substantially larger among men than among women in the USA, Canada and The Netherlands. CONCLUSIONS: Industrialized countries have varied widely in the extent of risk factor prevention, and its likely benefits for cardiometabolic mortality.
BACKGROUND: Cardiovascular disease mortality has declined and diabetes mortality has increased in high-income countries. We estimated the potential role of trends in population body mass index, systolic blood pressure, serum total cholesterol and smoking in cardiometabolic mortality decline in 26 industrialized countries. METHODS: Mortality data were from national vital statistics. Body mass index, systolic blood pressure and serum total cholesterol were from a systematic analysis of population-based data. We estimated the associations between change in cardiometabolic mortality and changes in risk factors, adjusted for change in per-capita gross domestic product. We calculated the potential contribution of risk factor trends to mortality decline. RESULTS: Between 1980 and 2009, age-standardized cardiometabolic mortality declined in all 26 countries, with the annual decline between <1% in Mexico to ≈ 5% in Australia. Across the 26 countries together, risk factor trends may have accounted for ≈ 48% (men) and ≈ 40% (women) of cardiometabolic mortality decline. Risk factor trends may have accounted for >60% of decline among men and women in Finland and Switzerland, men in New Zealand and France, and women in Italy; their benefits were smallest in Mexican, Portuguese, and Japanese men and Mexican women. Risk factor trends may have slowed down mortality decline in Chilean men and women and had virtually no effect in Argentinean women. The contributions of risk factors to mortality decline seemed substantially larger among men than among women in the USA, Canada and The Netherlands. CONCLUSIONS: Industrialized countries have varied widely in the extent of risk factor prevention, and its likely benefits for cardiometabolic mortality.
Authors: Sharon Saydah; Kai McKeever Bullard; Yiling Cheng; Mohammed K Ali; Edward W Gregg; Linda Geiss; Giuseppina Imperatore Journal: Obesity (Silver Spring) Date: 2014-04-15 Impact factor: 5.002
Authors: S G Sepanlou; M Sharafkhah; H Poustchi; M M Malekzadeh; A Etemadi; H Khademi; F Islami; A Pourshams; P D Pharoah; C C Abnet; P Brennan; P Boffetta; S M Dawsey; A Esteghamati; F Kamangar; R Malekzadeh Journal: J Hum Hypertens Date: 2015-06-11 Impact factor: 3.012
Authors: Majid Ezzati; Ziad Obermeyer; Ioanna Tzoulaki; Bongani M Mayosi; Paul Elliott; David A Leon Journal: Nat Rev Cardiol Date: 2015-06-16 Impact factor: 32.419
Authors: Andrew E Moran; Mohammad H Forouzanfar; Gregory A Roth; George A Mensah; Majid Ezzati; Christopher J L Murray; Mohsen Naghavi Journal: Circulation Date: 2014-02-26 Impact factor: 29.690